Showing 1 - 6 results of 6 for search 'Niccolò Bartalucci', query time: 0.03s Refine Results
  1. 1
    Resolving complex structural variants via nanopore sequencing

    Resolving complex structural variants via nanopore sequencing by Simone Romagnoli, Niccolò Bartalucci, Alessandro Maria Vannucchi

    Published 2023-08-01
    Get full text
    Article
  2. 2
    Non‐Fouling Multi‐Azide Polyoxazoline Brush‐co‐Polymers for Sensing Applications

    Non‐Fouling Multi‐Azide Polyoxazoline Brush‐co‐Polymers for Sensing Applications by Tobias Komsthöft, Niccolò Bartalucci, Mark W. Tibbitt, Samuele Tosatti, Stefan Zürcher

    Published 2024-12-01
    Get full text
    Article
  3. 3
    The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera

    The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera by Lisa Pieri, Costanza Bogani, Paola Guglielmelli, Maria Zingariello, Rosa Alba Rana, Niccolò Bartalucci, Alberto Bosi, Alessandro M. Vannucchi

    Published 2009-11-01
    Get full text
    Article
  4. 4
    Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2

    Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2 by Simone Romagnoli, Niccolò Bartalucci, Francesca Gesullo, Manjola Balliu, Stefania Bonifacio, Anair Graciela Lema Fernandez, Francesco Mannelli, Davide Bolognini, Elisabetta Pelo, Cristina Mecucci, Paola Guglielmelli, Alessandro Maria Vannucchi

    Published 2021-11-01
    Get full text
    Article
  5. 5
    Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia

    Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia by Elisabetta Antonioli, Alessandra Carobbio, Lisa Pieri, Alessandro Pancrazzi, Paola Guglielmelli, Federica Delaini, Vanessa Ponziani, Niccolò Bartalucci, Lorenzo Tozzi, Alberto Bosi, Alessandro Rambaldi, Tiziano Barbui, Alessandro M. Vannucchi

    Published 2010-08-01
    Get full text
    Article
  6. 6
    The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis

    The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis by Elena Genovese, Margherita Mirabile, Sebastiano Rontauroli, Stefano Sartini, Sebastian Fantini, Lara Tavernari, Monica Maccaferri, Paola Guglielmelli, Elisa Bianchi, Sandra Parenti, Chiara Carretta, Selene Mallia, Sara Castellano, Corrado Colasante, Manjola Balliu, Niccolò Bartalucci, Raffaele Palmieri, Tiziana Ottone, Barbara Mora, Leonardo Potenza, Francesco Passamonti, Maria Teresa Voso, Mario Luppi, Alessandro Maria Vannucchi, Enrico Tagliafico, Rossella Manfredini, on behalf of the Mynerva (MYeloid NEoplasms Research Venture AIRC)

    Published 2022-01-01
    Get full text
    Article

Search Tools: